62 related articles for article (PubMed ID: 1980369)
1. [FDA phase II and phase III drug evaluation of antipsychotic agents].
Yagi K
Seishin Shinkeigaku Zasshi; 1990; 92(9):584-92. PubMed ID: 1980369
[No Abstract] [Full Text] [Related]
2. [Difficulties of evaluation of the results of drug treatment of schizophrenia].
Welbel L
Psychiatr Pol; 1980; 14(1):51-7. PubMed ID: 6102774
[No Abstract] [Full Text] [Related]
3. An early phase II clinical trial of remoxipride in schizophrenia with measurement of plasma neuroleptic activity.
Chouinard G; Turnier L
Psychopharmacol Bull; 1986; 22(1):267-71. PubMed ID: 2873615
[No Abstract] [Full Text] [Related]
4. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
Akhondzadeh S; Safarcherati A; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
[TBL] [Abstract][Full Text] [Related]
5. Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636).
Hamner MB; Arvanitis LA; Miller BG; Link CG; Hong WW
Psychopharmacol Bull; 1996; 32(1):107-10. PubMed ID: 8927658
[TBL] [Abstract][Full Text] [Related]
6. ICI 204,636: a new atypical antipsychotic drug.
Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
[No Abstract] [Full Text] [Related]
7. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial.
Fleischhacker WW; Barnas C; Stuppäck CH; Unterweger B; Miller C; Hinterhuber H
Psychopharmacol Bull; 1989; 25(1):97-100. PubMed ID: 2570438
[No Abstract] [Full Text] [Related]
8. Ethical questions raised by a proposed randomized, double-blind study involving placebo, standard drug therapy, and experimental antipsychotic drug therapy for patients with schizophrenia.
Abrams RA; Veenhuis P
Clin Res; 1986 Jan; 34(1):6-9. PubMed ID: 2873917
[No Abstract] [Full Text] [Related]
9. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
Filip V; Faltus F; Hanáková S; Janecková E; Raboch J; Dobiásová A; Karen P; Posmurová M
Cesk Psychiatr; 1985 Feb; 81(1):6-14. PubMed ID: 2858269
[No Abstract] [Full Text] [Related]
10. Apomorphine in schizophrenia.
Hollister LE; Davis KL; Berger PA
Commun Psychopharmacol; 1980; 4(4):277-81. PubMed ID: 6115735
[No Abstract] [Full Text] [Related]
11. [Antipsychotic effects of caerulein on chronic schizophrenia].
Moroharu T; Watanabe N; Ito M
Seishin Shinkeigaku Zasshi; 1983; 85(9):611-5. PubMed ID: 6145173
[No Abstract] [Full Text] [Related]
12. Newer antipsychotics similar to older agents.
J Fam Pract; 2005 Dec; 54(12):1026. PubMed ID: 16370079
[No Abstract] [Full Text] [Related]
13. Clinical predictors of schizophrenic patient response to neuroleptics.
Korínková V
Act Nerv Super (Praha); 1989 Jun; 31(2):115-6. PubMed ID: 2572131
[No Abstract] [Full Text] [Related]
14. The AMDP system in international clinical trials: a double-blind comparison of fluperlapine and haloperidol.
Woggon B; Linden M; Beckmann H; Krebs E; Küfferle B; Müller-Oerlinghausen B; Pflug B; Schied HW
Psychopharmacol Bull; 1986; 22(1):47-51. PubMed ID: 2873619
[No Abstract] [Full Text] [Related]
15. Hormonal response to dehydroepiandrosterone administration in schizophrenia: findings from a randomized, double-blind, placebo-controlled, crossover study.
Strous RD; Gibel A; Maayan R; Weizman A; Ritsner MS
J Clin Psychopharmacol; 2008 Aug; 28(4):456-9. PubMed ID: 18626277
[No Abstract] [Full Text] [Related]
16. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
17. The interaction between superoxide dismutase and prolactin is involved in response to haloperidol and risperidone treatment in schizophrenia: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
J Clin Psychopharmacol; 2006 Feb; 26(1):103-5. PubMed ID: 16415724
[No Abstract] [Full Text] [Related]
18. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
[No Abstract] [Full Text] [Related]
19. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial.
Borison RL; Sinha D; Haverstock S; McLarnon MC; Diamond BI
Psychopharmacol Bull; 1989; 25(2):190-3. PubMed ID: 2574893
[No Abstract] [Full Text] [Related]
[Next] [New Search]
